Article
Pyrosequencing evaluation of low-frequency KRAS mutant alleles for EGF receptor therapy selection in metastatic colorectal carcinoma.
Future oncology (London, England) - 1 Apr 2014
Natalicchio Maria Iole, Improta Giuseppina, Zupa Angela, Cursio Olga Elisabetta, Stampone Emanuela, Possidente Luciana, Teresa Gerardi Assunta Maria, Vita Giulia, Martini Maurizio, Cassano Alessandra, Piccoli Claudia, Romito Sante, Aieta Michele, Antonetti Raffaele, Barone Carlo, Landriscina Matteo
Abstract excerpt
AIM: To evaluate whether pyrosequencing (PS) improves the KRAS mutational status predictive value. PATIENTS & METHODS: A retrospective analysis of KRAS mutations by PS and direct sequencing (DS) in 192 metastatic colorectal carcinomas (mCRCs), subgrouped in 51 KRAS mutated at PS and 141 KRAS wild-type at DS. RESULTS: DS failed to detect low-frequency KRAS mutations in four out of 51 mCRCs, whereas PS detected 12...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
